{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:15:09Z","timestamp":1761167709106,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.ghir.2009.07.001","type":"journal-article","created":{"date-parts":[[2009,8,6]],"date-time":"2009-08-06T06:07:10Z","timestamp":1249538830000},"page":"26-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discontinuation of hormone replacement therapy in young GH-treated hypopituitary women increases liver enzymes"],"prefix":"10.1016","volume":"20","author":[{"given":"Christian","family":"H\u00f8st","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens J.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens S.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens O.L.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus H.","family":"Gravholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ghir.2009.07.001_bib1","first-page":"574","article-title":"Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors","volume":"85","author":"Bulow","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8710","key":"10.1016\/j.ghir.2009.07.001_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"issue":"9254","key":"10.1016\/j.ghir.2009.07.001_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West midlands prospective hypopituitary study group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ghir.2009.07.001_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-07-0013","article-title":"Mortality and GH deficiency: a nationwide study","volume":"157","author":"Stochholm","year":"2007","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2009.07.001_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/eje.0.1360157","article-title":"Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults","volume":"136","author":"Markussis","year":"1997","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"10.1016\/j.ghir.2009.07.001_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen\/progestin replacement study (HERS) research group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ghir.2009.07.001_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.ghir.2009.07.001_bib8","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ghir.2009.07.001_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/er.2005-0020","article-title":"Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies","volume":"27","author":"Turgeon","year":"2006","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.ghir.2009.07.001_bib10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0008-6363(01)00466-7","article-title":"Estrogen replacement therapy, atherosclerosis, and vascular function","volume":"53","author":"Mikkola","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.ghir.2009.07.001_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/aje\/kwj079","article-title":"Combined analysis of women\u2019s health initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease","volume":"163","author":"Prentice","year":"2006","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.ghir.2009.07.001_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.fertnstert.2006.11.142","article-title":"Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study","volume":"88","author":"Castelo-Branco","year":"2007","journal-title":"Fertil. Steril."},{"issue":"12A","key":"10.1016\/j.ghir.2009.07.001_bib13","doi-asserted-by":"crossref","first-page":"47E","DOI":"10.1016\/S0002-9149(02)02413-X","article-title":"Effects of progestins in different hormone replacement therapy formulations on estrogen-induced lipid changes in postmenopausal women","volume":"89","author":"Shulman","year":"2002","journal-title":"Am. J. Cardiol."},{"issue":"1\u20135","key":"10.1016\/j.ghir.2009.07.001_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0960-0760(01)00135-2","article-title":"Alternations in hepatic expression of fatty-acid metabolizing enzymes in ArKO mice and their reversal by the treatment with 17beta-estradiol or a peroxisome proliferator","volume":"79","author":"Toda","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"12","key":"10.1016\/j.ghir.2009.07.001_bib15","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1172\/JCI9575","article-title":"Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice","volume":"105","author":"Nemoto","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.ghir.2009.07.001_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-0676.2001.021003183.x","article-title":"Effects of idoxifene and estradiol on NF-kappaB activation in cultured rat hepatocytes undergoing oxidative stress","volume":"21","author":"Omoya","year":"2001","journal-title":"Liver"},{"issue":"3","key":"10.1016\/j.ghir.2009.07.001_bib17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1023\/A:1022553119715","article-title":"Idoxifene and estradiol enhance antiapoptotic activity through estrogen receptor-beta in cultured rat hepatocytes","volume":"48","author":"Inoue","year":"2003","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.ghir.2009.07.001_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2265.2001.01321.x","article-title":"Hormone replacement therapy may improve hepatic function in women with Turner\u2019s syndrome","volume":"55","author":"Elsheikh","year":"2001","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"8","key":"10.1016\/j.ghir.2009.07.001_bib19","first-page":"2570","article-title":"Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner\u2019s syndrome, with important modulations by treatment with 17 beta-estradiol","volume":"82","author":"Gravholt","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2009.07.001_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2265.2001.01181.x","article-title":"Choosing an oestrogen replacement therapy in young adult women with Turner syndrome","volume":"54","author":"Guttmann","year":"2001","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"6","key":"10.1016\/j.ghir.2009.07.001_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/EJE-07-0070","article-title":"Quantitative liver functions in Turner syndrome with and without hormone replacement therapy","volume":"156","author":"Gravholt","year":"2007","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2009.07.001_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","article-title":"Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial","volume":"65","author":"McKenzie","year":"2006","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"3","key":"10.1016\/j.ghir.2009.07.001_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1440-1746.2007.04824.x","article-title":"Non-alcoholic fatty liver disease: further expression of the metabolic syndrome","volume":"22","author":"Tarantino","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.ghir.2009.07.001_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/eje.1.01898","article-title":"Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I","volume":"152","author":"Christiansen","year":"2005","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.ghir.2009.07.001_bib25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ajcn\/41.4.810","article-title":"Assessment of fat-free mass using bioelectrical impedance measurements of the human body","volume":"41","author":"Lukaski","year":"1985","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.ghir.2009.07.001_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.1985.tb01096.x","article-title":"Abnormal androgen and oestrogen metabolism in men with steroid sulphatase deficiency and recessive X-linked ichthyosis","volume":"23","author":"Lykkesfeldt","year":"1985","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"9","key":"10.1016\/j.ghir.2009.07.001_bib27","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s00125-005-1850-z","article-title":"Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications","volume":"48","author":"Frystyk","year":"2005","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ghir.2009.07.001_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.20026","article-title":"Vascular involvement of the liver in Turner\u2019s syndrome","volume":"39","author":"Roulot","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ghir.2009.07.001_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0895-4356(97)00237-0","article-title":"Morbidity in Turner syndrome","volume":"51","author":"Gravholt","year":"1998","journal-title":"J. Clin. Epidemiol."},{"issue":"11","key":"10.1016\/j.ghir.2009.07.001_bib30","first-page":"1197","article-title":"Effect of hormone replacement therapy on lipid metabolism in patients with premature ovarian failure and Turner\u2019s syndrome","volume":"46","author":"Yahata","year":"1994","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"Suppl.","key":"10.1016\/j.ghir.2009.07.001_bib31","first-page":"S186","article-title":"Non-alcoholic fatty liver disease","volume":"17","author":"Angulo","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.ghir.2009.07.001_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/jhep.2002.30690","article-title":"Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association","volume":"35","author":"Pagano","year":"2002","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ghir.2009.07.001_bib33","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2337\/diabetes.51.6.1889","article-title":"High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes","volume":"51","author":"Vozarova","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ghir.2009.07.001_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2009.07.001_bib35","doi-asserted-by":"crossref","unstructured":"American gastroenterological association medical position statement: nonalcoholic fatty liver disease. Gastroenterology 123(5) (2002) pp.1702\u20131704.","DOI":"10.1053\/gast.2002.36569"},{"issue":"32","key":"10.1016\/j.ghir.2009.07.001_bib36","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.3748\/wjg.v13.i32.4295","article-title":"Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection","volume":"13","author":"Shimizu","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"20","key":"10.1016\/j.ghir.2009.07.001_bib37","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1073\/pnas.200377097","article-title":"Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta","volume":"97","author":"Mueller","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ghir.2009.07.001_bib38","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocrinol. Rev."},{"issue":"5608","key":"10.1016\/j.ghir.2009.07.001_bib39","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1079562","article-title":"Angiogenesis-independent endothelial protection of liver: role of VEGFR-1","volume":"299","author":"LeCouter","year":"2003","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ghir.2009.07.001_bib40","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1023\/A:1018802407565","article-title":"Methimazole slows hepatocyte streaming in rats","volume":"42","author":"Oren","year":"1997","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.ghir.2009.07.001_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Glycemic effects of postmenopausal hormone therapy: the heart and estrogen\/progestin replacement. Study a randomized, double-blind, placebo-controlled trial","volume":"138","author":"Kanaya","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.ghir.2009.07.001_bib42","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1530\/EJE-09-0151","article-title":"Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study","volume":"160","author":"Pentti","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2009.07.001_bib43","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women","volume":"8","author":"Salpeter","year":"2006","journal-title":"Diabetes Obes. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2009.07.001_bib44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/eje.0.1510657","article-title":"Epidemiological, endocrine and metabolic features in Turner syndrome","volume":"151","author":"Gravholt","year":"2004","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2009.07.001_bib45","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.maturitas.2007.08.002","article-title":"Time course of liver lipid infiltration in ovariectomized rats: impact of a high-fat diet","volume":"58","author":"Paquette","year":"2007","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.ghir.2009.07.001_bib46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2265.1998.00383.x","article-title":"Plasma sex hormones are significantly associated with plasma leptin concentration in healthy subjects","volume":"48","author":"Paolisso","year":"1998","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"2","key":"10.1016\/j.ghir.2009.07.001_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1677\/joe.0.1540285","article-title":"Estrogen increases in vivo leptin production in rats and human subjects","volume":"154","author":"Shimizu","year":"1997","journal-title":"J. Endocrinol."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637409000872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637409000872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:45:29Z","timestamp":1761086729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637409000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1096637409000872"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2009.07.001","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discontinuation of hormone replacement therapy in young GH-treated hypopituitary women increases liver enzymes","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2009.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}